Literature DB >> 17214846

Novel host response therapeutic approaches to treat periodontal diseases.

Keith L Kirkwood1, Joni A Cirelli, Jill E Rogers, William V Giannobile.   

Abstract

Mesh：

Substances：

Year:  2007        PMID： 17214846      PMCID： PMC2570321          DOI： 10.1111/j.1600-0757.2006.00166.x

Source DB:  PubMed          Journal:  Periodontol 2000        ISSN： 0906-6713            Impact factor:   7.589


× No keyword cloud information.
  184 in total

1.  Soluble antagonists to interleukin-1 (IL-1) and tumor necrosis factor (TNF) inhibits loss of tissue attachment in experimental periodontitis.

Authors:  A J Delima; T Oates; R Assuma; Z Schwartz; D Cochran; S Amar; D T Graves
Journal:  J Clin Periodontol       Date:  2001-03       Impact factor: 8.728

Review 2.  The molecular basis of osteoclast differentiation and activation.

Authors:  T Suda; K Kobayashi; E Jimi; N Udagawa; N Takahashi
Journal:  Novartis Found Symp       Date:  2001

3.  Single-dose pharmacokinetics and pharmacodynamics of RWJ 67657, a specific p38 mitogen-activated protein kinase inhibitor: a first-in-human study.

Authors:  Dolly A Parasrampuria; Peter de Boer; Daksha Desai-Krieger; Andrew T Chow; C Richard Jones
Journal:  J Clin Pharmacol       Date:  2003-04       Impact factor: 3.126

4.  The discovery of RPR 200765A, a p38 MAP kinase inhibitor displaying a good oral anti-arthritic efficacy.

Authors:  L M Mclay; F Halley; J E Souness; J McKenna; V Benning; M Birrell; B Burton; M Belvisi; A Collis; A Constan; M Foster; D Hele; Z Jayyosi; M Kelley; C Maslen; G Miller; M C Ouldelhkim; K Page; S Phipps; K Pollock; B Porter; A J Ratcliffe; E J Redford; S Webber; B Slater; V Thybaud; N Wilsher
Journal:  Bioorg Med Chem       Date:  2001-02       Impact factor: 3.641

5.  Adenoviral delivery of osteoprotegerin ameliorates bone resorption in a mouse ovariectomy model of osteoporosis.

Authors:  B Bolon; C Carter; M Daris; S Morony; C Capparelli; A Hsieh; M Mao; P Kostenuik; C R Dunstan; D L Lacey; J Z Sheng
Journal:  Mol Ther       Date:  2001-02       Impact factor: 11.454

6.  The effect of alendronate sodium on alveolar bone loss in periodontitis (clinical trial).

Authors:  Una M El-Shinnawi; Salah Ibrahim El-Tantawy
Journal:  J Int Acad Periodontol       Date:  2003-01

Review 7.  The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction.

Authors:  D T Graves; D Cochran
Journal:  J Periodontol       Date:  2003-03       Impact factor: 6.993

8.  Signaling by toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages.

Authors:  M Hirschfeld; J J Weis; V Toshchakov; C A Salkowski; M J Cody; D C Ward; N Qureshi; S M Michalek; S N Vogel
Journal:  Infect Immun       Date:  2001-03       Impact factor: 3.441

9.  Clinical and radiological improvement of periodontal disease in patients with type 2 diabetes mellitus treated with alendronate: a randomized, placebo-controlled trial.

Authors:  M Rocha; L E Nava; C Vázquez de la Torre; F Sánchez-Márin; M E Garay-Sevilla; J M Malacara
Journal:  J Periodontol       Date:  2001-02       Impact factor: 6.993

10.  Therapeutic efficacy of a soluble receptor activator of nuclear factor kappaB-IgG Fc fusion protein in suppressing bone resorption and hypercalcemia in a model of humoral hypercalcemia of malignancy.

Authors:  B O Oyajobi; D M Anderson; K Traianedes; P J Williams; T Yoneda; G R Mundy
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701
View more
  56 in total

Review 1.  Periodontitis: a polymicrobial disruption of host homeostasis.

Authors:  Richard P Darveau
Journal:  Nat Rev Microbiol       Date:  2010-07       Impact factor: 60.633

2.  Phototargeting human periodontal pathogens in vivo.

Authors:  Nikolaos S Soukos; Jacyn Stultz; Abraham D Abernethy; J Max Goodson
Journal:  Lasers Med Sci       Date:  2013-12-18       Impact factor: 3.161

3.  Activity of antimicrobial peptide mimetics in the oral cavity: II. Activity against periopathogenic biofilms and anti-inflammatory activity.

Authors:  J Hua; R W Scott; G Diamond
Journal:  Mol Oral Microbiol       Date:  2010-12       Impact factor: 3.563

Review 4.  Toll gates to periodontal host modulation and vaccine therapy.

Authors:  George Hajishengallis
Journal:  Periodontol 2000       Date:  2009       Impact factor: 7.589

Review 5.  Revisiting the Page & Schroeder model: the good, the bad and the unknowns in the periodontal host response 40 years later.

Authors:  George Hajishengallis; Jonathan M Korostoff
Journal:  Periodontol 2000       Date:  2017-10       Impact factor: 7.589

Review 6.  Sexual Dimorphism in Immunity to Oral Bacterial Diseases: Intersection of Neutrophil and Osteoclast Pathobiology.

Authors:  M S Valerio; K L Kirkwood
Journal:  J Dent Res       Date:  2018-09-11       Impact factor: 6.116

Review 7.  The potential of p38 MAPK inhibitors to modulate periodontal infections.

Authors:  Keith L Kirkwood; Carlos Rossa
Journal:  Curr Drug Metab       Date:  2009-01       Impact factor: 3.731

8.  A novel murine model for chronic inflammatory alveolar bone loss.

Authors:  H S Oz; J L Ebersole
Journal:  J Periodontal Res       Date:  2009-07-08       Impact factor: 4.419

Review 9.  Host-response therapeutics for periodontal diseases.

Authors:  William V Giannobile
Journal:  J Periodontol       Date:  2008-08       Impact factor: 6.993

Review 10.  Minocycline: far beyond an antibiotic.

Authors:  N Garrido-Mesa; A Zarzuelo; J Gálvez
Journal:  Br J Pharmacol       Date:  2013-05       Impact factor: 8.739
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.